PreventionGenetics (PG) is pleased to announce PG Discovery, the latest enhancement to our PGxome® whole exome and PGnome™ (coming very soon) whole genome sequencing tests. With PG Discovery, we will report relevant rare variants in genes with limited evidence of disease association, commonly known as candidate genes.
Our shipping department can send saliva kits directly to patient’s homes. Review our saliva kit instructions for healthcare providers.
We are pleased to announce that six of our employees matched in the Genetic Counseling Graduate School Admissions Match program this cycle. 492 students will enter genetic counseling training programs this year from 50 accredited training programs.
Congratulations to our Genetic Counseling Assistants, Chelsea Reierson, Lauren Rachow, Maria Rhine, Mryia Hubert, Eryn Mares, as well as our R&D technician, Farrah Uphoff, who are celebrating their acceptance.
Since many conferences understandably had to cancel their 2020 meetings due to COVID-19, PreventionGenetics' invites you to visit our virtual booth! It's not the same as getting to see and interact with our team in person but we hope you enjoy this online experience with us.
Autism Spectrum Disorders (ASDs) and Intellectual Disability (ID) are a heterogeneous group of neurodevelopmental disorders that are inherited in a multifactorial fashion. PreventionGenetics’ ASD-ID Comprehensive Panel is exome-based and allows for reflex to PGxome whole exome sequencing. The ASD-ID panel also includes exome-wide copy number variant (CNV) detection. This method allows for cost-effective identification and reporting of potentially important, large CNVs across the full exome in conjunction with any sequencing variants and/or smaller CNVs identified within the panel.
